SoftBank Drops $500M on Agile Robots, Pushing Humanoid Race to Industrial Scale

SoftBank has written a $500 million check to Agile Robots, valuing the Munich-based humanoid robotics startup at $8.5 billion in a round that also drew Nvidia, Hitachi, and T.Capital. The funding—announced in a Bloomberg-reported statement—positions Agile as Europe’s most valuable privately held robotics company, surpassing Neura Robotics’ $7 billion valuation from June.

The capital will fuel Agile’s push into large-scale production. The company’s ambitions are clear: it aims to accelerate manufacturing capacity, though the exact timeline remains to be seen. That’s a sharp contrast to the sector’s early-stage deployments, where most humanoid robots remain confined to research labs or limited pilot programs. Agile’s CEO, Zhaopeng Chen, has framed the race to commercialize physical AI as a “capital-intensive war,” and this funding puts him in a stronger position to fight it.

For SoftBank, the investment is a double-edged play. The group has made robotics a cornerstone of its AI strategy, but its ambitions have faced setbacks—most notably, Chinese regulators blocking its $5.4 billion bid for ABB’s robotics business in Shanghai. Agile, however, offers a more direct route: a European-based company already testing its robots with industrial partners. The $500 million round also hints at a shift from SoftBank’s earlier $800 million target, suggesting either a recalibration of expectations or a more measured approach to funding in a volatile market.

Agile’s path to profitability hinges on scaling beyond pilots. The company sells a smaller robot to universities and labs, where deployments generate real-world data to improve its systems. But the real test will be whether its humanoid models—designed for manufacturing—can deliver on promises of efficiency. Chen has acknowledged lingering challenges, including battery life, weight distribution, and the quality of training data. Yet the funding puts Agile in a position to accelerate development, even as competitors like DeepSeek and Winverse push into robotics AI from a different angle.

The round also raises questions about Agile’s long-term strategy. Chen has suggested the funding strengthens his ability to consider an IPO, though no timeline was set. With valuations often built on projections rather than revenue, Agile’s ability to deliver at scale will be the acid test. If it succeeds, the company could redefine the humanoid market; if it stumbles, it may join the ranks of high-profile robotics startups that failed to scale.

What to watch next: Whether Agile can secure manufacturing contracts beyond its current partners, proving its robots can handle real-world production. How SoftBank balances its robotics bets after the ABB setback, especially as Chinese and U.S. competitors ramp up. The pace of Agile’s expansion into new markets, where demand for humanoid robots is growing but still unproven at scale.

The funding round isn’t just about money—it’s about who will control the next wave of physical AI. Agile’s bet is that it can outpace the competition by moving faster than the rest. The question is whether the market will follow.

Sources: thenextweb.com · sifted.eu